GnRH-a Pretreatment Doses and Frozen-Thawed Blastocyst Transfer Outcomes in PCOS Patients: A Retrospective Cohort Study
GnRH-a pretreatment at either 1.5 mg or 3.75 mg did not confer a clear benefit over HRT alone in PCOS patients undergoing FET. The number of embryos transferred remains the primary determinant of pregnancy outcome. Larger prospective studies are warranted to validate these findings.
Authors
- Xudong Liang (ORCID: https://orcid.org/0009-0002-2762-1790)
- Ying Qiu (ORCID: https://orcid.org/0009-0008-5645-9095)
- Rong Li (ORCID: https://orcid.org/0009-0002-0667-4367)
- Xi Li (ORCID: https://orcid.org/0009-0008-4480-8251)
- Qinfu Song (ORCID: https://orcid.org/0009-0001-4991-5725)
- Yanqun Zhou (ORCID: https://orcid.org/0009-0005-2604-6167)
- Jingjing Wu (ORCID: https://orcid.org/0009-0002-1472-3640)
Institutions
- Guangxi Medical University (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- International Journal of Women s Health
- Published
- 2025-11-01
- DOI
- https://doi.org/10.2147/ijwh.s563596
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangxi Key Research and Development Program